public health.”(Quinones 249) It is difficult to establish the fact that more fatal problem is the widespread addiction to prescription painkillers. Moreover, the suppliers of these drugs are respectable physicians, primary doctors and behind them, multibillion-dollar pharmaceutical companies. Purdue Pharma, as one of the pharmaceutical companies, making on abuse OxyContin [contain large doses of oxycodone that is similar to heroin], as legitimate use as s painkiller in a medical field that lead to the actual overdose deaths and rise in criminal activity in society. Mark Mariani, a writer and educator based in Hoboken, New Jersey, states the facts in his article How the American Opiate Epidemic Was Started by One Pharmaceutical Company, “on December 12, 1995, the Food and Drug Administration approved the opioid analgesic OxyContin. It hit the market in 1996. In its first year, OxyContin accounted for $45 million in sales for its manufacturer, Stamford, Connecticut-based pharmaceutical company Purdue Pharma.” () Mariani's point is that, these OxyContin that was intended to revolutionize the treatment of
public health.”(Quinones 249) It is difficult to establish the fact that more fatal problem is the widespread addiction to prescription painkillers. Moreover, the suppliers of these drugs are respectable physicians, primary doctors and behind them, multibillion-dollar pharmaceutical companies. Purdue Pharma, as one of the pharmaceutical companies, making on abuse OxyContin [contain large doses of oxycodone that is similar to heroin], as legitimate use as s painkiller in a medical field that lead to the actual overdose deaths and rise in criminal activity in society. Mark Mariani, a writer and educator based in Hoboken, New Jersey, states the facts in his article How the American Opiate Epidemic Was Started by One Pharmaceutical Company, “on December 12, 1995, the Food and Drug Administration approved the opioid analgesic OxyContin. It hit the market in 1996. In its first year, OxyContin accounted for $45 million in sales for its manufacturer, Stamford, Connecticut-based pharmaceutical company Purdue Pharma.” () Mariani's point is that, these OxyContin that was intended to revolutionize the treatment of